Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.25 -3.1%
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
- TransUnion CFO Todd Cello to step down after 29 years
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
